Citation Impact
Citing Papers
Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
2014
Hormonal Evidence for Altered Responsiveness to Social Stress in Major Depression
2000
Cerebrospinal Fluid Corticotropin-Releasing Factor and Perceived Early-Life Stress in Depressed Patients and Healthy Control Subjects
2003
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Neuroendocrine aspects of hypercortisolism in major depression
2003
No health without mental health
2007 Standout
Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis
1999
Adrenergic α2C-Receptors Modulate the Acoustic Startle Reflex, Prepulse Inhibition, and Aggression in Mice
1998 StandoutNobel
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications.
1991
Corticotropin Releasing Hormone in the Pathophysiology of Melancholic and Atypical Depression and in the Mechanism of Action of Antidepressant Drugs
1995
Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers
1997
Role of glutamate in schizophrenia: integrating excitatory avenues of research
2008
Pharmacoepidemiology of anabolic androgenic steroids: a review
2004
Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone
1998 StandoutNobel
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Serum levels of soluble IL-2 receptor α, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration
1999
Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression
1992
The corticotropin-releasing hormone test in patients with posttraumatic stress disorder
1989
Perceived discrimination and health: A meta-analytic review.
2009 Standout
Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review
2007
Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology
2006 Standout
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
Schizophrenia
2009 Standout
Convergence of biological and psychological perspectives on cognitive coordination in schizophrenia
2003
Serum‐soluble interleukin‐2 receptors in neuroleptic‐naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia
1994
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain
2007 Standout
Anabolic steroid abuse and dependence
2002
Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia
1997
Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders
2008
Sympathetic Nervous System Activity in Major Depression
1994
The free-energy principle: a unified brain theory?
2010 Standout
Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics
2000
Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology
2002
Stress, antidepressant drugs, and the locus coeruleus
1994
Glucocorticoid Dysregulations and Their Clinical Correlates
2009
Effects of stress throughout the lifespan on the brain, behaviour and cognition
2009 Standout
Glutamatergic dysfunction in schizophrenia: From basic neuroscience to clinical psychopharmacology
2008
The adolescent brain and age-related behavioral manifestations
2000 Standout
Dissociations in the expression of the sedative effects of triazolam
1995
Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes
2009
Glutamate and Schizophrenia: Phencyclidine, N‐Methyl‐d‐Aspartate Receptors, and Dopamine–Glutamate Interactions
2007
Binge eating as escape from self-awareness.
1991 Standout
The family of sensorimotor gating disorders: Comorbidities or diagnostic overlaps?
2006
NMDA receptor hypofunction model of schizophrenia
1999
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia
2000 StandoutNobel
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Effects of Clozapine and Fluphenazine Treatment on Responses to m-Chlorophenylpiperazine Infusions in Schizophrenia
1993
Acute Stressors and Cortisol Responses: A Theoretical Integration and Synthesis of Laboratory Research.
2004 Standout
Selective impairments in the stress response in schizophrenic patients
2000
The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease
1988
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Blunted cortisol response to a psychosocial stressor in schizophrenia
1998
Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research.
2016 Standout
Cytokines and depression: fortuitous or causative association?
1999
A review of sex differences in peer relationship processes: Potential trade-offs for the emotional and behavioral development of girls and boys.
2006 Standout
Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder
1991
Neocortical excitation/inhibition balance in information processing and social dysfunction
2011 StandoutNature
Dose Response and Dose Equivalence of Antipsychotics
2004
Protective and Damaging Effects of Stress Mediators
1998 Standout
Toxicological findings and manner of death in autopsied users of anabolic androgenic steroids
2005
Distinct Neuronal Coding Schemes in Memory Revealed by Selective Erasure of Fast Synchronous Synaptic Transmission
2012 StandoutNobel
Rethinking schizophrenia
2010 StandoutNature
The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance
1994
Criminality Among Individuals Testing Positive for the Presence of Anabolic Androgenic Steroids
2006
Cytokine profiles in schizophrenic patients treated with risperidone
2002
Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies
2001
A Separate Disease Within the Syndrome of Schizophrenia
2001
Beyond diathesis stress: Differential susceptibility to environmental influences.
2009 Standout
Neurobiology of Depression
2002 Standout
Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression
1997
Cortisol and Cytokines in Chronic and Treatment-Resistant Patients with Schizophrenia: Association with Psychopathology and Response to Antipsychotics
2005
Neurotransmitter interactions in schizophrenia—therapeutic implications
1999 StandoutNobel
Major Depressive Disorder
2008 Standout
Variable foraging demand rearing: sustained elevations in cisternal cerebrospinal fluid corticotropin-releasing factor concentrations in adult primates
2001
The role of corticotropin-releasing factor in depression and anxiety disorders
1999
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
2011 Standout
Dysregulation in the Suicide Brain: mRNA Expression of Corticotropin-Releasing Hormone Receptors and GABAAReceptor Subunits in Frontal Cortical Brain Region
2004
Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression
1999
The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
2007
Clinical and Biochemical Manifestations of Depression
1988
AKT/PKB Signaling: Navigating the Network
2017 Standout
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
2003 Standout
The Neuropsychopharmacology of Phencyclidine From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia
1999
CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteers
1997
Reduction of immune function in life stress and depression
1990
Psychological Stress and the Human Immune System: A Meta-Analytic Study of 30 Years of Inquiry.
2004 Standout
An association between increased serum-soluble interleukin-2 receptors and a disturbance in muscle force in schizophrenic patients
1997
Dopamine in Motivational Control: Rewarding, Aversive, and Alerting
2010 Standout
The role of 5-HT2A receptors in antipsychotic activity
1995
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
Stressors, Stress, and Neuroendocrine Integration of the Adaptive Response: The 1997 Hans Selye Memorial Lecture
1998
If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans.
2007 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Schizophrenia: A neural diathesis-stress model.
1997
The molecular neurobiology of depression
2008 StandoutNature
Membrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia
2003
Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states
2002
The dopamine-serotonin relationship in clozapine response
1993
Neuroendocrine and behavioral effects of high-dose anabolic steroid administration in male normal volunteers
2003
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
2003
Delirium in Mechanically Ventilated Patients
2001 Standout
Personality as independent predictor of long-term mortality in patients with coronary heart disease
1996 Standout
The CRH stimulation test in bereaved subjects with and without accompanying depression
1988
Depressive symptoms and the risk of type 2 diabetes mellitus in a US sample
2002
Cognitive effects of corticosteroids
1990
Depressive Symptoms and the Risk of Type 2 Diabetes
2004
Depression Following Myocardial Infarction
1993 Standout
Effect of Risperidone on Serum Cytokines
2001
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy
1999 Standout
A default mode of brain function
2001 Standout
The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia
1999
Effect of neuroleptic administration on serum levels of soluble IL-2 receptor-alpha and IL-1 receptor antagonist in schizophrenic patients
2005
What are the functional consequences of neurocognitive deficits in schizophrenia?
1996 Standout
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions*
2000 Standout
About Sleep's Role in Memory
2013 Standout
Putting the 'A' in atypical: does α2-adrenoceptor antagonism account for the therapeutic advantage of new antipsychotics?
1994
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments
2002
NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex
2004
Neurochemical abnormalities of anorexia nervosa and bulimia nervosa
1989
Are cross-species measures of sensorimotor gating useful for the discovery of procognitive cotreatments for schizophrenia?
2006
Psychiatric Morbidity during the Early Phase of Coronary Care for Myocardial Infarction: Association with Cardiac Diagnosis and Outcome*
1992
Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
2007
Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients
2001
Mouse neurexin-1α deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments
2009 StandoutNobel
Works of David Pickar being referenced
Clozapine Blunts N-Methyl-d-Aspartate Antagonist-Induced Psychosis: A Study with Ketamine
1997
Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteers
1988
Increased serum soluble interleukin-2 receptors in caucasian and Korean schizophrenic patients
1994
Clinical and Biologic Response to Clozapine in Patients With Schizophrenia
1992
Autonomic effects of clozapine in schizophrenia: Comparison with placebo and fluphenazine
1993
Clinical investigation of monoamine neurotransmitter interactions
1993
Cerebrospinal Fluid and Behavioral Changes After Methyltestosterone Administration
2001
CSF corticotropin-releasing hormone in depressed patients and normal control subjects
1987
Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers
1997
High plasma norepinephrine levels in patients with major affective disorder
1982
The corticotropin-releasing hormone stimulation test in chronic schizophrenia
1986
Diazepam-induced amnesia: a neuropharmacological model of an "organic amnestic syndrome"
1987